Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29534796 | 0.86 | AHR (0.50) | AHRESR1ESR2FAAHMGLL | |
| SCHEMBL23660862 | 0.86 | AHR (0.50) | AHRESR1ESR2FAAHMGLL | |
| SCHEMBL13328077 | 0.83 | AHR (0.44) | AHRESR1ESR2MGLLMEN1 | |
| SCHEMBL12440940 | 0.81 | AHR (0.41) | AHRESR1ESR2MGLLMEN1 | |
| SCHEMBL13429672 | 0.80 | AHR (0.33) | AHR | |
| SCHEMBL12195289 | 0.80 | AHR (0.52) | AHRMGLL | |
| SCHEMBL13326597 | 0.79 | MGLL (0.41) | AHRMGLLMEN1MAPTKMT2A | |
| SCHEMBL15583795 | 0.79 | AHR (0.40) | AHRESR1ESR2FAAHMGLL | |
| SCHEMBL18545086 | 0.77 | AHR (0.46) | AHRFAAHMGLLMEN1KMT2A | |
| SCHEMBL13125131 | 0.77 | AHR (0.46) | AHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110309341-A1 | AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMATION CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20110309341-A1 | AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMATION CO., LTD. (JP) | 2011-12-22 | — | — | US | disclosed |
| US-20100230666-A1 | AMINE-TYPE POLYMERIC COMPOUND, AND LIGHT-EMITTING ELEMENT COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100230666-A1 | AMINE-TYPE POLYMERIC COMPOUND, AND LIGHT-EMITTING ELEMENT COMPRISING THE SAME | AHR, ARNT, MLLT1 | AHR 1/4885MMP2 4852/4885MMP9 4773/4885 |
| US-20110309341-A1 | AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | AHR, HRH3, HRH4 | AHR 1/4885MMP2 4795/4885MMP9 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.